Regeneris Medical

What Regeneris Medical does

Regeneris Medical is a privately held, founder-led regenerative medicine practice headquartered in Westwood, Massachusetts. Founded in 2009 by Dr. Ryan Welter (MD, PhD, former Brown University professor), the company operates an outpatient clinical practice plus a Clinical Research Division that runs FDA-governed cellular therapy trials. Its core technology is Stromal Vascular Fraction (SVF) — stem cells extracted from adipose tissue via liposuction and combined with Platelet-Rich Plasma (PRP) — deployed across a portfolio of branded protocols: BioKnee (knee regeneration), BioHip (hip regeneration), O-Stem (female sexual wellness), P-Stem/P-Shot (male sexual wellness), Celutone, Cellu-Lift, and Regenerative Breast. Services are delivered through four wholly-owned sub-brands — Regeneris Medspa, New England Hair Restoration, Elite Men's Health, and Regeneris Cosmetics — each with its own consumer-facing website.

The company's business model is direct-to-consumer elective medicine priced on a per-procedure basis. BioKnee is listed at $5,000–$7,500 (with an earlier range of $2,500–$7,500) and BioHip under $10,000, positioned as 75–90% cheaper than the surgical alternatives they replace ($39,000–$49,500). Because these treatments are categorized as investigational, they are cash-pay and not typically reimbursed by insurance. The go-to-market combines content marketing via the company blog, organic social (Facebook, Instagram, YouTube), referral/affiliate partners, active participation at international hair-restoration conferences (ISHRS, FUEASIA UAE, FUE Europe), and a concierge medical-tourism offering that includes virtual consultations, airport pickup, and luxury accommodations. Customer segments are horizontal across orthopedics, anti-aging/aesthetics, hair restoration, and sexual wellness, all served by the same underlying SVF+PRP technology.

The customer base is a long tail of individual cash-pay patients — there are no enterprise contracts, no disclosed institutional referral partners beyond affiliate practitioners, and no insurance reimbursement. Public materials cite "hundreds of grateful patients" since 2009 and 15% year-over-year revenue growth on the company homepage. The company reports 11–50 employees, four sub-brand websites, and operates a small multi-location footprint in the Boston metro area with concierge reach into international medical tourism.

Name

Regeneris Medical

Legal name

Regeneris Medical

Website

https://regenerismedical.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Regeneris Medical is a founder-led, Boston-area outpatient regenerative medicine practice using SVF stem cell and PRP therapies across branded protocols (BioKnee, BioHip, O-Stem, P-Stem) and four sub-brands (Medspa, Hair Restoration, Men's Health, Cosmetics), selling elective cash-pay procedures directly to consumers.

Ownership category

akta.pro rank

Product category

Regenerative Medicine

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Scientific Research and Development Services (5417)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Regenerative Orthopedics & Sports Medicine (Tendon/Ligament/Joint) (HLAMANAF)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Platelet-Rich Plasma (PRP) & Blood-Derived Orthobiologics (HLAMANAB), Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics) (HLAAAGAL)

Keywords

• Regenerative medicine
• Stem cell therapy
• Hair restoration
• Orthopedic treatments
• Aesthetic medicine

Headquarters

HQ city

North Attleboro

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Regenerative Medical Procedures: Revenue generated from outpatient regenerative medicine procedures including stem cell therapies, PRP treatments, and surgical procedures. Procedures are priced individually based on complexity and treatment area. Common treatments include BioKnee ($2,500-$7,500), BioHip (under $10,000), and sexual wellness protocols.
2. Clinical Research Services: Revenue from conducting clinical trials for cellular therapies being developed by various drug developers. Clinical testing includes volunteer patients managed under FDA guidelines for experimental treatments.
3. Consultation Fees: Initial consultation services to evaluate patient candidacy for cellular therapy procedures. Consultation contact is facilitated through website forms and phone inquiries.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Regeneris Medical provides outpatient regenerative medicine procedures using patients' own adult stem cells harvested via Stromal Vascular Fraction (SVF) from adipose tissue and combined with Platelet Rich Plasma (PRP) therapy. The company delivers branded protocols (BioKnee, BioHip, O-Stem, P-Stem/P-Shot) across orthopedic, hair restoration, sexual wellness, and aesthetic use cases through its Westwood and Boston-area offices and multiple specialty sub-brands.

Product overview

Regeneris Medical operates as a healthcare and clinical research organization specializing in regenerative medicine and cellular therapies. The company offers a portfolio of branded treatment protocols including Regeneris BioKnee™ (biologic knee replacement), BioHip Protocol (hip regeneration), O-Stem Protocol (women's sexual wellness), and P-Stem Protocol/P-Shot™ (men's sexual wellness), alongside sub-brands in hair restoration (New England Hair Restoration), medspa services (Regeneris Medspa), men's health (Elite Men's Health), and cosmetic surgery (Regeneris Cosmetics). Core technologies include Stromal Vascular Fraction (SVF) for stem cell extraction from adipose tissue and Platelet Rich Plasma (PRP) therapy. The company also maintains a Clinical Research Division conducting trials for cellular therapies.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• BioKnee costs $2,500-$7,500 vs. traditional TKR at ~$49,000 (90-95% cost savings)
• +4 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and regional.

• International Society of Hair Restoration Surgery (ISHRS)coreStrategic or Co-development Partner · 1 January 2024Dr. Welter actively participates in ISHRS conferences and was featured at the 25th Annual World Congress in Prague, Czech Republic. The society is a key professional organization in the hair restoration field and Regeneris Medical's participation validates their expertise in the specialty.
• FUEASIA UAEcoreStrategic or Co-development Partner · 1 January 2024Dr. Welter participates in FUEASIA UAE events, international hair restoration conferences focused on FUE techniques. These conferences provide opportunities to share expertise and learn about latest developments in follicular unit extraction.
• FUE EuropecoreStrategic or Co-development Partner · 1 January 2024Active participation in FUE Europe conferences and events, positioning Regeneris Medical as a leader in the European and global hair restoration community.
• Cronos Med Center, BucharestregionalStrategic or Co-development Partner · 1 January 2024International collaboration with Cronos Med Center in Bucharest, Romania. Part of Dr. Welter's global network of regenerative medicine practitioners and hair restoration experts.
• CBS TV / WCVB BostonregionalStrategic or Co-development PartnerRegeneris Medical's Clinical Research Division was featured on CBS TV (WCVB Boston) covering new developments in cellular therapies for migraines. Media coverage validates their position as innovators in the field.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BioXcellerator: Stem cell therapy clinic treating orthopedic, neurological, and inflammatory conditions using autologous and allogeneic cell therapies. Comparable in regenerative medicine focus and treatment of degenerative joint disease.
• HairClub: Established North American hair restoration and prevention provider with both surgical and non-surgical offerings. Comparable to Regeneris Medical's New England Hair Restoration sub-brand in customer base and service line.
• Bosley: Largest U.S. hair restoration chain offering surgical FUE/FUT hair transplants and non-surgical treatments. Directly comparable to Regeneris Medical's New England Hair Restoration sub-brand and Dr. Welter's microFUE technique.
• Ziering Medical: National hair restoration practice led by celebrity surgeons, offering FUE and FUT hair transplants. Comparable to Regeneris Medical's hair restoration services in customer base and clinical offering.
• Swiss Medica: International stem cell therapy clinic treating orthopedic, neurological, and autoimmune conditions with adult stem cells. Comparable in treatment menu (SVF, PRP, MSC therapies) and cash-pay medical tourism model.
• The biostation: Concierge regenerative and longevity medicine practice offering hormone therapy, PRP, and stem cell treatments. Comparable to Regeneris Medical in cash-pay model, concierge patient experience, and men's/women's wellness segments.
• Celltex Therapeutics: U.S./Mexico-based autologous stem cell therapy provider focused on orthopedic and degenerative conditions. Comparable to Regeneris Medical in core biologics platform and investigational-treatment positioning.
• QC Kinetix: National franchise operating non-surgical regenerative medicine clinics focused on joint pain and orthopedic conditions using PRP and other biologics. Most directly comparable to Regeneris Medical's BioKnee and BioHip protocols in patient base and treatment modality.
• StemCell Institute (Panama): International regenerative medicine clinic offering autologous stem cell treatments for orthopedic, autoimmune, and degenerative conditions. Comparable to Regeneris Medical in core technology (adult mesenchymal stem cells) and medical tourism positioning.

Broad incumbents

• Restore Hyper Wellness: Franchise wellness brand offering IV therapy, cryotherapy, hormone optimization, and recovery services across U.S. locations. Overlaps with Regeneris Medical's wellness and anti-aging segments but does not offer stem cell procedures.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@regenerismedical
• Facebookfacebook.com/regenerismedical
• Instagraminstagram.com/regenerismed
• Xx.com/regenerismed
• LinkedInlinkedin.com/company/regeneris-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regeneris Medical